- Details
- Hits: 404
New research reveals a stark warning for cannabis users: marijuana significantly increases the risk of dangerous heart rhythm problems that can prove fatal.
A large-scale study published in August 2025 by researchers from the University of California, Georgetown University, and multiple other medical institutions found that cannabis use substantially raises the likelihood of developing serious cardiac arrhythmias. The findings show cannabis users face more than triple the risk of ventricular tachycardia and ventricular fibrillation compared to non-users.
Understanding the Risk
The retrospective study analysed electronic health records from 68 U.S. healthcare organizations, examining over 210,000 cannabis users matched with a similar number of control subjects. Researchers found 97 cases of ventricular tachycardia or fibrillation among cannabis users versus only 35 cases in the control group, representing a hazard ratio of 3.078.
Ventricular arrhythmias represent the most severe type of irregular heartbeat. These conditions occur when the heart’s lower chambers beat too quickly or chaotically, potentially preventing the heart from pumping blood effectively. Without immediate treatment, ventricular fibrillation can cause sudden cardiac death within minutes.
Beyond Ventricular Arrhythmias
The study documented elevated risks across multiple types of heart rhythm disorders. Cannabis users showed 1,895 cases of atrial fibrillation or flutter compared to 1,332 in the control group, with a 55% increased risk. Paroxysmal tachycardia occurred in 1,065 cannabis users versus 672 controls, representing a 79% increased risk, while premature beats affected 1,135 cannabis users compared to 745 controls, a 74% increase.
Atrial fibrillation emerged as the most common arrhythmia among cannabis users, though less immediately dangerous than ventricular arrhythmias. Atrial fibrillation still carries serious consequences, including increased stroke risk and heart failure.
Why Cannabis Affects Heart Rhythm
Multiple mechanisms may explain how cannabis triggers arrhythmias, including THC’s ability to block cardiac ion channels and prolong the QT interval. THC also enhances sympathetic nervous system activity through CB1 receptor activation, increasing heart rate and susceptibility to irregular rhythms.
Cannabis can cause coronary vasospasm and endothelial dysfunction, creating conditions that promote arrhythmias. Chronic use may lead to cardiac inflammation and fibrosis, causing atrial remodelling directly linked to atrial fibrillation development.
Research suggests the highest risk period occurs within one to two hours after cannabis use, indicating acute exposure poses immediate danger.
A Growing Public Health Concern
As cannabis legalization expands, hospitalization rates for cannabis-related arrhythmias have increased 31% over the past decade. The rise in arrhythmia-related hospitalizations appears particularly pronounced among teenage cannabis users.
Cannabis-induced arrhythmias disproportionately affect young, otherwise healthy individuals without structural heart disease, challenging assumptions that heart rhythm problems primarily afflict older adults with existing cardiovascular conditions.
The study used propensity score matching to ensure fair comparison between groups, accounting for age, sex, cardiovascular risk factors, and medication use. This rigorous methodology strengthens confidence in the findings.
What This Means for Users
Healthcare providers should counsel patients about cardiovascular risks associated with cannabis, particularly those with pre-existing heart conditions. The cardiovascular effects of marijuana deserve serious consideration as legal access continues expanding nationwide.
For individuals using or considering cannabis, these findings provide important context. Heart arrhythmias represent serious medical emergencies requiring immediate attention. Anyone experiencing symptoms like rapid heartbeat, chest pain, dizziness, or fainting should seek medical care promptly.
The research adds to mounting evidence documenting adverse cardiovascular effects of cannabis use. As the scientific community continues investigating these risks, current data already provide clear cause for concern about marijuana’s impact on heart health.
Source (WRD News)
- Details
- Hits: 665
(An Ed Sheeran moment!)
The Turning Point: In a revealing poem featured in the collection, Matthew McConaughey describes how cannabis evolved from recreational enjoyment into something far more problematic. Matthew McConaughey quitting cannabis represents a significant shift in his personal journey. He recounts the contrast between earlier experiences with the drug and its deteriorating effects over time.
McConaughey explains that what began as casual cannabis use became increasingly detrimental to his functioning. Rather than providing inspiration, the substance began causing paralysis and obsessive overthinking. He describes finding himself fixated on trivial details for extended periods, convinced they held significance when they did not.
A Catalyst for Change: A particularly striking moment prompted his reassessment of cannabis dependence. Matthew McConaughey reveals that on one occasion, he became so engrossed in listening to music whilst under the influence that he missed his own birthday celebration entirely. This incident underscored how cannabis had begun interfering with his ability to engage meaningfully with life. (Full Story WRD News)
- Details
- Hits: 411
Mounting scientific evidence continues to challenge the narrative that cannabis is a harmless substance, with alarming new research demonstrating significant THC effects on fertility and embryonic development.
A groundbreaking study conducted by researchers in Canada and Israel has uncovered disturbing links between THC exposure and chromosomal abnormalities in human embryos created through IVF. The findings add to growing concerns about the drug’s impact on reproductive health at a time when cannabis use amongst pregnant women is reportedly increasing.
Chromosomal Chaos
The research team’s analysis revealed that embryos exposed to THC experienced widespread genetic disruption. When comparing treated embryos to controls, scientists identified 89 genes that became overactive and 227 genes that became suppressed—clear evidence of substantial biochemical interference.
Higher THC concentrations proved even more damaging, with 402 genes showing increased activity and 62 displaying reduced function. These dramatic shifts in genetic expression suggest that the cannabis impact on reproduction extends deep into cellular processes critical for healthy development.
Perhaps most concerning, the study documented a 9% increase in aneuploidy—a condition where embryos possess an incorrect number of chromosomes. This abnormality frequently prevents successful conception or leads to developmental problems. The research also found that THC exposure elevated the likelihood of complex aneuploidy, involving the gain or loss of multiple chromosomes simultaneously.
Male Fertility Under Threat
These findings complement well-established research demonstrating THC effects on fertility in men. A comprehensive 2019 systematic review examined chronic cannabis users and found striking correlations between consumption frequency and sperm quality.
Men smoking cannabis 10 or more times weekly showed significantly lower sperm counts compared to those using it 5 to 9 times per week, suggesting a dose-dependent relationship. A Danish study involving 1,215 participants reinforced these conclusions, revealing that weekly cannabis users had 28% lower sperm concentration and 29% lower total sperm count than non-users.
Epigenetic Concerns Mount
This summer, researchers uncovered evidence that cannabis use can permanently alter DNA expression through methylation—the addition of methyl groups to DNA molecules. This process can affect how genes function without changing the underlying genetic code itself, potentially passing consequences to future generations.
The cannabis impact on reproduction now appears to operate through multiple mechanisms, from direct chromosomal damage to epigenetic modifications that may have long-lasting effects.
Vulnerable Populations at Risk
The Wall Street Journal recently highlighted a troubling trend: increasing numbers of pregnant women turning to marijuana to manage pain and anxiety. Ironically, robust scientific data indicates that cannabis actually exacerbates both conditions rather than alleviating them.
This disconnect between perception and reality reflects the success of industry marketing efforts that have positioned cannabis as a natural, safe alternative to conventional treatments. The consequences of this messaging are now becoming apparent, with expectant mothers potentially exposing their developing babies to significant harm.
A Growing Body of Evidence
The latest research on THC effects on fertility represents just one piece of an increasingly worrying puzzle. Scientific studies have now documented cannabis-related harm across multiple organ systems, including the brain, heart, lungs, and the genetic mechanisms that control cellular function.
The cumulative evidence paints a picture starkly different from the “safe and natural” image promoted by commercial interests. For couples planning to conceive, individuals undergoing fertility treatment, and pregnant women, the message from science is becoming unmistakably clear: cannabis poses serious risks to reproductive health and embryonic development.
The Path Forward
As cannabis legalisation expands across various jurisdictions, the importance of evidence-based public health messaging has never been greater. The recent findings regarding the cannabis impact on reproduction underscore the urgent need for comprehensive education about the drug’s genuine risks, particularly for those of reproductive age.
Healthcare providers working with patients considering pregnancy or undergoing fertility treatment must be equipped with current research to offer informed guidance. The romantic notion of cannabis as a benign natural remedy simply cannot withstand scientific scrutiny, especially when the health of future generations hangs in the balance.
The latest study examining THC effects on fertility serves as a stark reminder that what we put into our bodies can have profound consequences—not just for ourselves, but for the children we hope to bring into the world.
Source: The Drug Report
- Details
- Hits: 416
Interest in the use of cannabis and cannabinoids to treat chronic non-cancer pain is increasing, because of their potential to reduce opioid dose requirements. We aimed to investigate cannabis use in people living with chronic non-cancer pain who had been prescribed opioids, including their reasons for use and perceived effectiveness of cannabis; associations between amount of cannabis use and pain, mental health, and opioid use; the effect of cannabis use on pain severity and interference over time; and potential opioid-sparing effects of cannabis.
Findings: 1514 participants completed the baseline interview and were included in the study from Aug 20, 2012, to April 14, 2014. Cannabis use was common, and by 4-year follow-up, 295 (24%) participants had used cannabis for pain. Interest in using cannabis for pain increased from 364 (33%) participants (at baseline) to 723 (60%) participants (at 4 years). At 4-year follow-up, compared with people with no cannabis use, we found that participants who used cannabis had a greater pain severity score (risk ratio 1·14, 95% CI 1·01–1·29, for less frequent cannabis use; and 1·17, 1·03–1·32, for daily or near-daily cannabis use), greater pain interference score (1·21, 1·09–1·35; and 1·14, 1·03–1·26), lower pain self-efficacy scores (0·97, 0·96–1·00; and 0·98, 0·96–1·00), and greater generalised anxiety disorder severity scores (1·07, 1·03–1·12; and 1·10, 1·06–1·15). We found no evidence of a temporal relationship between cannabis use and pain severity or pain interference, and no evidence that cannabis use reduced prescribed opioid use or increased rates of opioid discontinuation.
Interpretation: Cannabis use was common in people with chronic non-cancer pain who had been prescribed opioids, but we found no evidence that cannabis use improved patient outcomes. People who used cannabis had greater pain and lower self-efficacy in managing pain, and there was no evidence that cannabis use reduced pain severity or interference or exerted an opioid-sparing effect. As cannabis use for medicinal purposes increases globally, it is important that large well designed clinical trials, which include people with complex comorbidities, are conducted to determine the efficacy of cannabis for chronic non-cancer pain.
(Source: The Lancet – Public Health https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(18)30110-5/fulltext)
Also see
- Details
- Hits: 360
Unintentional marijuana ingestions in children under 5 rose over 1,000% in 7 years, with edibles and pandemic-related factors fuelling the trend.
Unintentional marijuana ingestions among children younger than 5 years have risen more than 1,000% in the past seven years, according to research presented at the American Academy of Paediatrics (AAP) 2025 National Conference & Exhibition in Denver, Colorado.1,2
The retrospective study, Rising Trends in Paediatric Marijuana Ingestions: A Retrospective Analysis of the Impact of COVID-19 on Emergency Department Presentations, reviewed over 2,300 paediatric emergency department (ED) cases from 2016 through 2023. Researchers found sharp increases in exposures during the COVID-19 pandemic, with children most often consuming cannabis edibles that resembled candy.
“Even young children in states where marijuana is not legal are being hospitalized after unintentionally ingesting cannabis products—often edibles that look like candy,” said study author Brittain Robinson, MD, FAAP, of the University of Tennessee Health Science Center.